Teva Recalls Famotidine Tablets Due to Weight Specification Failures
Teva Pharmaceuticals USA is recalling 28,188 bottles of Famotidine 20 mg tablets because they failed tablet weight specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity score when no specific injuries or hospitalizations are reported in the source text.
Plain-English summary
Teva Pharmaceuticals USA is recalling 28,188 bottles of Famotidine Tablets USP, 20 mg, 100 count bottles. The recall involves Lot # 3429066 with an expiration date of 06/2018. The product is distributed nationwide.
The recall was initiated because the tablets failed to meet specifications for tablet weight. This is a Class II recall, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have this product should contact their pharmacist or healthcare provider for guidance on how to dispose of the medication or obtain a replacement.
The recalled product
- Product
- FAMOTIDINE (FAMOTIDINE)
- Brand
- FAMOTIDINE
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Prescription Drug
- Hazard
- Affected units
- 28,188
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 3429066
- exp 06/2018
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · FAMOTIDINE
- CriticalFamotidine injection vials recalled after endotoxin results exceeded the limit
FDA (Drugs) · 2025-12-03
- ModerateFamotidine tablets recalled for carton labeling error on strength
FDA (Drugs) · 2023-07-26
- SevereAurobindo Recalls Famotidine 40mg Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2021-03-10
- LowHF Acquisition Recalls Famotidine Injection Due to Temperature Abuse
FDA (Drugs) · 2020-07-29
- LowDr. Reddy's Recalls Famotidine Tablets Due to Impurity Failure
FDA (Drugs) · 2017-10-18
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · quality defect
See all →- ModerateDicyclomine Hydrochloride Capsules Recalled for Empty Capsules
FDA (Drugs) · 2026-08-12
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMedline Lidocaine HCL Injection Ampules Recalled for Quality Issues
FDA (Devices) · 2026-07-08
- ModerateMedline Convenience Kits Block Tray recalled due to quality defects
FDA (Devices) · 2026-07-08
- ModerateMedline Ophthalmic Pack with Lidocaine Injection Kits Recalled
FDA (Devices) · 2026-07-08